Glioblastoma initiating cells are sensitive to histone demethylase inhibition due to epigenetic deregulation

Jan Philipp Mallm*, Paul Windisch, Alva Biran, Zoltan Gal, Sabrina Schumacher, Rainer Glass, Christel Herold-Mende, Eran Meshorer, Martje Barbus, Karsten Rippe

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

28 Citationer (Scopus)

Abstract

Tumor-initiating cells are a subpopulation of cells that have self-renewal capacity to regenerate a tumor. Here, we identify stem cell-like chromatin features in human glioblastoma initiating cells (GICs) and link them to a loss of the repressive histone H3 lysine 9 trimethylation (H3K9me3) mark. Increasing H3K9me3 levels by histone demethylase inhibition led to cell death in GICs but not in their differentiated counterparts. The induction of apoptosis was accompanied by a loss of the activating H3 lysine 9 acetylation (H3K9ac) modification and accumulation of DNA damage and downregulation of DNA damage response genes. Upon knockdown of histone demethylases, KDM4C and KDM7A both differentiation and DNA damage were induced. Thus, the H3K9me3–H3K9ac equilibrium is crucial for GIC viability and represents a chromatin feature that can be exploited to specifically target this tumor subpopulation.

OriginalsprogEngelsk
TidsskriftInternational Journal of Cancer
Vol/bind146
Udgave nummer5
Sider (fra-til)1281-1292
Antal sider12
ISSN0020-7136
DOI
StatusUdgivet - 2020
Udgivet eksterntJa

Bibliografisk note

Funding Information:
This work was funded by the Cooperation Program in Cancer Research of the German Cancer Research Center (DKFZ) and Israel's Ministry of Science, Technology and Space (MOST) via grants Ca146 and Ca180 to K.R. and E.M. J.P.M. was supported by the German CellNetworks Cluster of Excellence (EXC81) and RG and CHM by the Anni Hofmann foundation.

Publisher Copyright:
© 2019 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC

Citationsformater